A citation-based method for searching scientific literature

Pooja Ghatalia, Charity J Morgan, Youjin Je, Paul L Nguyen, Quoc-Dien Trinh, Toni K Choueiri, Guru Sonpavde. Crit Rev Oncol Hematol 2015
Times Cited: 73







List of co-cited articles
1606 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Jose Luis Zamorano, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J Lenihan, Gregory Y H Lip, Alexander R Lyon,[...]. Eur Heart J 2016
35

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
Tammy F Chu, Maria A Rupnick, Risto Kerkela, Susan M Dallabrida, David Zurakowski, Lisa Nguyen, Kathleen Woulfe, Elke Pravda, Flavia Cassiola, Jayesh Desai,[...]. Lancet 2007
755
28


Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.
Toni K Choueiri, Fabio A B Schutz, Youjin Je, Jonathan E Rosenberg, Joaquim Bellmunt. J Clin Oncol 2010
299
24

The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients.
Philip S Hall, Lauren C Harshman, Sandy Srinivas, Ronald M Witteles. JACC Heart Fail 2013
122
23

Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Daniela Cardinale, Alessandro Colombo, Giulia Bacchiani, Ines Tedeschi, Carlo A Meroni, Fabrizio Veglia, Maurizio Civelli, Giuseppina Lamantia, Nicola Colombo, Giuseppe Curigliano,[...]. Circulation 2015
790
23

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Syed S Mahmood, Michael G Fradley, Justine V Cohen, Anju Nohria, Kerry L Reynolds, Lucie M Heinzerling, Ryan J Sullivan, Rongras Damrongwatanasuk, Carol L Chen, Dipti Gupta,[...]. J Am Coll Cardiol 2018
652
23

Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
Douglas B Johnson, Justin M Balko, Margaret L Compton, Spyridon Chalkias, Joshua Gorham, Yaomin Xu, Mellissa Hicks, Igor Puzanov, Matthew R Alexander, Tyler L Bloomer,[...]. N Engl J Med 2016
23

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
P Ghatalia, Y Je, M D Kaymakcalan, G Sonpavde, T K Choueiri. Br J Cancer 2015
81
21

Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Robert J Motzer, Thomas E Hutson, David Cella, James Reeves, Robert Hawkins, Jun Guo, Paul Nathan, Michael Staehler, Paul de Souza, Jaime R Merchan,[...]. N Engl J Med 2013
20


Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.
Thomas Force, Daniela S Krause, Richard A Van Etten. Nat Rev Cancer 2007
549
19

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, Pavel Hoffmann, Jeanette Schulz-Menger, Morten W Fagerland, Berit Gravdehaug, Florian von Knobelsdorff-Brenkenhoff, Åse Bratland, Tryggve H Storås,[...]. Eur Heart J 2016
354
19

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A Sebag, Deborah A Agler, Luigi P Badano,[...]. J Am Soc Echocardiogr 2014
720
19


Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.
Saro H Armenian, Christina Lacchetti, Ana Barac, Joseph Carver, Louis S Constine, Neelima Denduluri, Susan Dent, Pamela S Douglas, Jean-Bernard Durand, Michael Ewer,[...]. J Clin Oncol 2017
584
19

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, J Herrmann, C Porter, A R Lyon, P Lancellotti,[...]. Ann Oncol 2020
298
19

Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.
Christopher J Richards, Youjin Je, Fabio A B Schutz, Daniel Y C Heng, Susan M Dallabrida, Javid J Moslehi, Toni K Choueiri. J Clin Oncol 2011
130
17

Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
Daniela Cardinale, Alessandro Colombo, Giuseppina Lamantia, Nicola Colombo, Maurizio Civelli, Gaia De Giacomi, Mara Rubino, Fabrizio Veglia, Cesare Fiorentini, Carlo M Cipolla. J Am Coll Cardiol 2010
686
17

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A Sebag, Deborah A Agler, Luigi P Badano,[...]. Eur Heart J Cardiovasc Imaging 2014
542
17

Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis.
Husam Abdel-Qadir, Josee-Lyne Ethier, Douglas S Lee, Paaladinesh Thavendiranathan, Eitan Amir. Cancer Treat Rev 2017
116
17

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Negrier, Cezary Szczylik, Sindy T Kim,[...]. N Engl J Med 2007
16

Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Michael L Maitland, George L Bakris, Henry R Black, Helen X Chen, Jean-Bernard Durand, William J Elliott, S Percy Ivy, Carl V Leier, Joann Lindenfeld, Glenn Liu,[...]. J Natl Cancer Inst 2010
270
16

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.
Daniela Cardinale, Alessandro Colombo, Maria T Sandri, Giuseppina Lamantia, Nicola Colombo, Maurizio Civelli, Giovanni Martinelli, Fabrizio Veglia, Cesare Fiorentini, Carlo M Cipolla. Circulation 2006
645
16

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Saro H Armenian, Melissa M Hudson, Renee L Mulder, Ming Hui Chen, Louis S Constine, Mary Dwyer, Paul C Nathan, Wim J E Tissing, Sadhna Shankar, Elske Sieswerda,[...]. Lancet Oncol 2015
298
16

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma.
Manuela Schmidinger, Christoph C Zielinski, Ursula M Vogl, Andja Bojic, Marija Bojic, Christoph Schukro, Marquerite Ruhsam, Michael Hejna, Herwig Schmidinger. J Clin Oncol 2008
456
15

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
15


Congestive heart failure risk in patients with breast cancer treated with bevacizumab.
Toni K Choueiri, Erica L Mayer, Youjin Je, Jonathan E Rosenberg, Paul L Nguyen, Georges R Azzi, Joaquim Bellmunt, Harold J Burstein, Fabio A B Schutz. J Clin Oncol 2011
206
15

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
Brian I Rini, Darrel P Cohen, Dongrui R Lu, Isan Chen, Subramanian Hariharan, Martin E Gore, Robert A Figlin, Michael S Baum, Robert J Motzer. J Natl Cancer Inst 2011
425
13

Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Sui Zhang, Xiaobing Liu, Tasneem Bawa-Khalfe, Long-Sheng Lu, Yi Lisa Lyu, Leroy F Liu, Edward T H Yeh. Nat Med 2012
13

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G Curigliano, D Cardinale, T Suter, G Plataniotis, E de Azambuja, M T Sandri, C Criscitiello, A Goldhirsch, C Cipolla, F Roila. Ann Oncol 2012
501
13

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.
Bonnie Ky, Mary Putt, Heloisa Sawaya, Benjamin French, James L Januzzi, Igal A Sebag, Juan Carlos Plana, Victor Cohen, Jose Banchs, Joseph R Carver,[...]. J Am Coll Cardiol 2014
322
13

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
13

Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
Paaladinesh Thavendiranathan, Frédéric Poulin, Ki-Dong Lim, Juan Carlos Plana, Anna Woo, Thomas H Marwick. J Am Coll Cardiol 2014
641
13

Evaluation and management of patients with heart disease and cancer: cardio-oncology.
Joerg Herrmann, Amir Lerman, Nicole P Sandhu, Hector R Villarraga, Sharon L Mulvagh, Manish Kohli. Mayo Clin Proc 2014
199
13

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.
Edith Pituskin, John R Mackey, Sheri Koshman, Davinder Jassal, Marshall Pitz, Mark J Haykowsky, Joseph J Pagano, Kelvin Chow, Richard B Thompson, Larissa J Vos,[...]. J Clin Oncol 2017
218
13

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.
Mônica Samuel Avila, Silvia Moreira Ayub-Ferreira, Mauro Rogerio de Barros Wanderley, Fatima das Dores Cruz, Sara Michelly Gonçalves Brandão, Vagner Oliveira Carvalho Rigaud, Marília Harumi Higuchi-Dos-Santos, Ludhmila Abrahão Hajjar, Roberto Kalil Filho, Paulo Marcelo Hoff,[...]. J Am Coll Cardiol 2018
241
13

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Richard M Steingart, George L Bakris, Helen X Chen, Ming-Hui Chen, Thomas Force, S Percy Ivy, Carl V Leier, Glenn Liu, Daniel Lenihan, JoAnn Lindenfeld,[...]. Am Heart J 2012
82
12


Sorafenib in advanced clear-cell renal-cell carcinoma.
Bernard Escudier, Tim Eisen, Walter M Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Negrier, Christine Chevreau, Ewa Solska, Apurva A Desai,[...]. N Engl J Med 2007
12

Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis.
Wei-Xiang Qi, Da-Liu Min, Zan Shen, Yuan-Jue Sun, Feng Lin, Li-Na Tang, Ai-Na He, Yang Yao. Int J Cancer 2013
68
13


Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Frank A Scappaticci, Jamey R Skillings, Scott N Holden, Hans-Peter Gerber, Kathy Miller, Fairooz Kabbinavar, Emily Bergsland, James Ngai, Eric Holmgren, Jiuzhou Wang,[...]. J Natl Cancer Inst 2007
677
12

VEGF inhibition and renal thrombotic microangiopathy.
Vera Eremina, J Ashley Jefferson, Jolanta Kowalewska, Howard Hochster, Mark Haas, Joseph Weisstuch, Catherine Richardson, Jeffrey B Kopp, M Golam Kabir, Peter H Backx,[...]. N Engl J Med 2008
12



Risk of ischemic heart disease in women after radiotherapy for breast cancer.
Sarah C Darby, Marianne Ewertz, Paul McGale, Anna M Bennet, Ulla Blom-Goldman, Dorthe Brønnum, Candace Correa, David Cutter, Giovanna Gagliardi, Bruna Gigante,[...]. N Engl J Med 2013
12

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
Frederika A van Nimwegen, Michael Schaapveld, Cécile P M Janus, Augustinus D G Krol, Eefke J Petersen, John M M Raemaekers, Wouter E M Kok, Berthe M P Aleman, Flora E van Leeuwen. JAMA Intern Med 2015
265
12

Adjuvant trastuzumab in HER2-positive breast cancer.
Dennis Slamon, Wolfgang Eiermann, Nicholas Robert, Tadeusz Pienkowski, Miguel Martin, Michael Press, John Mackey, John Glaspy, Arlene Chan, Marek Pawlicki,[...]. N Engl J Med 2011
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.